Cargando…
Repurposing Metformin for Vascular Disease
Metformin has been used as an oral anti-hyperglycaemic drug since the late 1950s; however, following the release in 1998 of the findings of the 20-year United Kingdom Prospective Diabetes Study (UKPDS), metformin use rapidly increased and today is the first-choice anti-hyperglycaemic drug for patien...
Autores principales: | Triggle, Chris R., Marei, Isra, Ye, Kevin, Ding, Hong, Anderson, Todd J., Hollenberg, Morley D., Hill, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286558/ https://www.ncbi.nlm.nih.gov/pubmed/35909294 http://dx.doi.org/10.2174/0929867329666220729154615 |
Ejemplares similares
-
Association between Statins Types with Incidence of Liver Cancer: An Updated Meta-analysis
por: Zhang, Xingfen, et al.
Publicado: (2023) -
3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations
por: Marei, Isra, et al.
Publicado: (2022) -
Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes
por: Marei, Isra, et al.
Publicado: (2022) -
The Flavonoid Components of Scutellaria baicalensis: Biopharmaceutical Properties and their Improvement using Nanoformulation Techniques
por: Wang, Jilin, et al.
Publicado: (2023) -
Arginine-Glycine-Aspartic Acid-anchored Curcumin-based Nanotherapeutics Inhibit Pyroptosis-induced Cytokine Release Syndrome for In Vivo and In Vitro Sepsis Applications
por: Shi, Yi, et al.
Publicado: (2023)